Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lauren A Gamble

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Gastrointestinal Endoscopy Clinics of North America|November 20, 2021
Surveillance and Surgical Considerations in Hereditary Diffuse Gastric CancerLauren A Gamble, Jeremy L Davis
JAMA Surgery|January 6, 2021
Hereditary Diffuse Gastric Cancer Syndrome and the Role of CDH1: A ReviewLauren A Gamble, Theo Heller, Jeremy L Davis
Frontiers in Genetics|October 17, 2022
Frequent cleft lip and palate in families with pathogenic germline <i>CDH1</i> variantsBenjamin L Green, Grace-Ann Fasaye, Sarah G Samaranayake, et al.
JAMA Surgery|October 13, 2021
Association Between Hereditary Lobular Breast Cancer Due to CDH1 Variants and Gastric Cancer RiskLauren A Gamble, Alexander Rossi, Grace-Ann Fasaye, et al.
Annals of Surgical Oncology|November 22, 2019
Staging Laparoscopy is Underutilized in the Management of Gastric AdenocarcinomaEric M Groh, Shreya Gupta, Zachary J Brown, et al.
STAR Protocols|November 5, 2023
Protocol for isolation of signet ring cells from human gastric mucosaSarah G Samaranayake, Lauren A Gamble, Cassidy Bowden, et al.
NPJ Breast Cancer|September 27, 2023
Defining features of hereditary lobular breast cancer due to CDH1 with magnetic resonance imaging and tumor characteristicsLauren A Gamble, Paul H McClelland, Martha E Teke, et al.
The Journal of Clinical Endocrinology and Metabolism|March 23, 2023
Micronutrient Supplementation and Bone Health After Prophylactic Total Gastrectomy in Patients With CDH1 VariantsLauren A Gamble, Rachael Lopez, Suraj Rajasimhan, et al.
Journal of Gastrointestinal Oncology|May 14, 2020
Targeting CA 19-9 with a humanized monoclonal antibody at the time of surgery may decrease recurrence rates for patients undergoing resections for pancreatic cancer, cholangiocarcinoma and metastatic colorectal cancerShreya Gupta, James D McDonald, Reed I Ayabe, et al.
Journal of Medical Genetics|July 11, 2022
Decision-making and regret in patients with germline <i>CDH1</i> variants undergoing prophylactic total gastrectomyLauren A Gamble, Robert R C Grant, Sarah G Samaranayake, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Gastrointestinal Endoscopy Clinics of North America|November 20, 2021
Surveillance and Surgical Considerations in Hereditary Diffuse Gastric CancerLauren A Gamble, Jeremy L Davis
JAMA Surgery|January 6, 2021
Hereditary Diffuse Gastric Cancer Syndrome and the Role of CDH1: A ReviewLauren A Gamble, Theo Heller, Jeremy L Davis
Frontiers in Genetics|October 17, 2022
Frequent cleft lip and palate in families with pathogenic germline <i>CDH1</i> variantsBenjamin L Green, Grace-Ann Fasaye, Sarah G Samaranayake, et al.
JAMA Surgery|October 13, 2021
Association Between Hereditary Lobular Breast Cancer Due to CDH1 Variants and Gastric Cancer RiskLauren A Gamble, Alexander Rossi, Grace-Ann Fasaye, et al.
Annals of Surgical Oncology|November 22, 2019
Staging Laparoscopy is Underutilized in the Management of Gastric AdenocarcinomaEric M Groh, Shreya Gupta, Zachary J Brown, et al.
STAR Protocols|November 5, 2023
Protocol for isolation of signet ring cells from human gastric mucosaSarah G Samaranayake, Lauren A Gamble, Cassidy Bowden, et al.
NPJ Breast Cancer|September 27, 2023
Defining features of hereditary lobular breast cancer due to CDH1 with magnetic resonance imaging and tumor characteristicsLauren A Gamble, Paul H McClelland, Martha E Teke, et al.
The Journal of Clinical Endocrinology and Metabolism|March 23, 2023
Micronutrient Supplementation and Bone Health After Prophylactic Total Gastrectomy in Patients With CDH1 VariantsLauren A Gamble, Rachael Lopez, Suraj Rajasimhan, et al.
Journal of Gastrointestinal Oncology|May 14, 2020
Targeting CA 19-9 with a humanized monoclonal antibody at the time of surgery may decrease recurrence rates for patients undergoing resections for pancreatic cancer, cholangiocarcinoma and metastatic colorectal cancerShreya Gupta, James D McDonald, Reed I Ayabe, et al.
Journal of Medical Genetics|July 11, 2022
Decision-making and regret in patients with germline <i>CDH1</i> variants undergoing prophylactic total gastrectomyLauren A Gamble, Robert R C Grant, Sarah G Samaranayake, et al.
Pageof 2